Astera Labs (NASDAQ:ALAB) Stock Falls 3.7% – What’s Next?

Astera Labs, Inc. (NASDAQ:ALAB) shares fell 3.7% on Monday. The stock traded as low as $342.00 and last traded at $351.31. 4,064,165 shares were traded during trading, a decline of 22% from the average session volume of 5,230,728 shares. The stock had previously closed at $364.62.

Analysts Set New Price Targets

A number of analysts have commented on ALAB shares. Morgan Stanley upped their price target on shares of Astera Labs to $335.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. Zacks Research raised Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Barclays upped their target price on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Susquehanna lifted their target price on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Finally, Roth Capital reissued a “buy” rating and issued a $450.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $348.33.

Astera Labs Price Performance

The firm’s fifty day moving average price is $306.77 and its two-hundred day moving average price is $278.19. The stock has a market cap of $62.08 billion, a price-to-earnings ratio of 177.15 and a beta of 3.77.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same period last year, the business posted $0.44 EPS. The firm’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Transactions at Astera Labs

In other news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the completion of the sale, the director owned 253,863 shares in the company, valued at $71,114,642.19. The trade was a 41.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan Dyckerhoff sold 8,994 shares of the stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total value of $2,472,990.24. Following the completion of the transaction, the director owned 3,309 shares in the company, valued at approximately $909,842.64. This represents a 73.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 396,059 shares of company stock valued at $122,605,660. Company insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of ALAB. QRG Capital Management Inc. raised its position in Astera Labs by 8.7% in the second quarter. QRG Capital Management Inc. now owns 4,775 shares of the company’s stock worth $2,306,000 after acquiring an additional 381 shares during the period. Silicon Valley Capital Partners grew its stake in shares of Astera Labs by 99.0% during the 2nd quarter. Silicon Valley Capital Partners now owns 1,990 shares of the company’s stock worth $961,000 after acquiring an additional 990 shares during the period. Twin Peaks Capital Ltd purchased a new stake in Astera Labs in the 2nd quarter worth about $4,830,000. Capstone Financial Advisors Inc. purchased a new stake in Astera Labs during the second quarter valued at about $274,000. Finally, Sequoia Financial Advisors LLC increased its stake in shares of Astera Labs by 19.0% in the second quarter. Sequoia Financial Advisors LLC now owns 3,677 shares of the company’s stock worth $1,776,000 after purchasing an additional 588 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.